BALLANTE, FLAVIO
 Distribuzione geografica
Continente #
EU - Europa 810
NA - Nord America 693
AS - Asia 137
AF - Africa 23
SA - Sud America 5
Totale 1.668
Nazione #
US - Stati Uniti d'America 688
GB - Regno Unito 391
SE - Svezia 187
IT - Italia 126
CN - Cina 51
IN - India 49
FI - Finlandia 45
SG - Singapore 33
TG - Togo 23
BG - Bulgaria 16
DE - Germania 14
IE - Irlanda 13
UA - Ucraina 12
CA - Canada 5
BR - Brasile 2
CL - Cile 2
JP - Giappone 2
AR - Argentina 1
AT - Austria 1
ES - Italia 1
GR - Grecia 1
MY - Malesia 1
NL - Olanda 1
RO - Romania 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 1.668
Città #
Fairfield 85
Uppsala 72
Chandler 68
Ashburn 52
Fasano 48
Beijing 43
Stockholm 40
Woodbridge 39
Seattle 37
Cambridge 35
Wilmington 35
Princeton 28
Rome 27
Houston 26
Plano 26
Lomé 23
Helsinki 19
Singapore 18
Sofia 15
Boston 14
Dublin 13
Des Moines 10
Lawrence 10
Millbury 10
Ann Arbor 9
Saint Louis 8
Norwalk 7
San Paolo di Civitate 7
Andover 6
Cagliari 6
Dearborn 6
Littlehampton 6
San Diego 6
Mannheim 5
Toronto 5
Hjo 4
Mariestad 4
New York 4
Jacksonville 3
Tampa 3
Buffalo 2
Bühl 2
Dallas 2
Grafing 2
Mountain View 2
Saarbrücken 2
San Mateo 2
Sapporo 2
Shenyang 2
Solna 2
Athens 1
Barcelona 1
Bremen 1
Cassino 1
Chengdu 1
Como 1
Falls Church 1
Federal 1
Florence 1
Fremont 1
Göteborg 1
Hefei 1
Highland 1
Kaohsiung 1
Kuala Lumpur 1
Los Angeles 1
Milan 1
Monmouth Junction 1
Nanjing 1
Ningbo 1
Perugia 1
Redwood City 1
Reston 1
San Francisco 1
San Jose 1
Torino 1
Totale 928
Nome #
Application of Medicinal Chemistry Methods on Different Classes of Drugs 133
Pharmacophore assessment through 3-D QSAR: evaluation of the predictive ability on new derivatives by the application on a series of antitubercular agents 112
Design, synthesis and biological evaluation of new classes of thieno[3,2-d]pyrimidinone and thieno[1,2,3]triazine as inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2) 104
2-(Alkyl/aryl)amino-6-benzylpyrimidin-4(3H)-ones as inhibitors of wild-type and mutant HIV-1: enantioselectivity studies. 102
3-D QSAutogrid/R: An alternative procedure to build 3-D QSAR models. methodologies and applications 101
Histone Deacetylase Inhibitors: Structure-Based Modeling and Isoform-Selectivity Prediction 89
Exploring the role of 2-chloro-6-fluoro substitution in 2-alkylthio-6-benzyl-5-alkylpyrimidin-4(3H)-ones: effects in HIV-1-infected cells and in HIV-1 reverse transcriptase enzymes 85
Comprehensive model of wild-type and mutant HIV-1 reverse transciptases 70
3-D QSAR SERVER – A 3-D QSAR models database for virtual screening 65
A combined structure and ligand-based application on BSAO as an encouraging approach in anti-cancer therapy. 61
VEGFR-2 Inhibitors. New perspectives from molecular modeling 60
Hsp90 Inhibitors (II). Combining ligand-based and structure-based approaches for Virtual Screening application 58
Molecular Docking Of Biaryl Tetrazolyl Ureas As Inhibitors Of Endocannabinoid Metabolism 51
Hsp90 Inhibitors (I). Definition of 3-D QSAutogrid/R Models as a Tool for Virtual Screening 50
Design And Synthesis Of 2-Indolyl-Thieno[2,3-D]Pyrimidinones As Potential Inhibitors Of VEGFR-2. 49
Computational strategies to design new highly potential BSAO polyamine substrates 49
Design and synthesis of new inhibitors of VEGFR-2. 48
An alternative method for generating 3-D QSAR models using free software 46
Histone Deacetylase Inhibitors. The Development of a Model for Target Prediction 45
null 45
Histone Deacetylase inhibitors. The development of a model for target-selectivity prediction 44
Beta-secretase: quantitative structure-activity relationships (3-D QSARs) and evaluation of predictive ability 42
R/AUTOGRID/ADT Combination As An Alternative To Build 3-D QSAR Models. Methodologies And Applications 42
Histone deacetylase inhibitors: Comparative Binding Energy and QSAR studies for target selectivity prediction 41
RCMD 3-D QSAR SERVER an online 3-D QSAR models database 41
Interactions between new polyamine analogs and bovine serum amine oxidase. 40
Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors 12
Totale 1.685
Categoria #
all - tutte 3.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.802


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020181 0 4 1 10 23 22 26 19 19 26 28 3
2020/2021172 7 17 1 9 6 26 2 5 19 27 29 24
2021/2022233 4 21 15 10 33 4 7 25 14 19 28 53
2022/2023282 51 62 21 22 23 36 12 15 17 6 5 12
2023/2024157 6 23 8 8 6 22 3 36 0 15 19 11
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 1.685